Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation

被引:57
|
作者
Pizarro, M. D. [2 ]
Rodriguez, J. V. [2 ]
Mamprin, M. E. [2 ]
Fuller, B. J. [3 ,4 ]
Mann, B. E. [5 ]
Motterlini, R. [6 ,7 ]
Guibert, E. E. [1 ]
机构
[1] Univ Nacl Rosario, UNESCO Chair Cryobiol, Fac Ciencias Bioquim & Farmaceut, Dept Ciencias Biol, RA-2000 Rosario, Santa Fe, Argentina
[2] Univ Nacl Rosario, UNESCO Chair Cryobiol, Fac Ciencias Bioquim & Farmaceut, Dept Ciencias Fisiol, RA-2000 Rosario, Santa Fe, Argentina
[3] UMESCO Chair Cryobiol, UCL, Royal Free & UCL Med Sch, Univ Dept Surg, London MW3 2QG, England
[4] UMESCO Chair Cryobiol, UCL, Royal Free & UCL Med Sch, Liver Transplant Unit, London MW3 2QG, England
[5] Univ Sheffield, Dept Chem, Sheffield S10 2TN, S Yorkshire, England
[6] Northwick Pk Inst Med Res, Dept Surg Res, Harrow, Middx, England
[7] Italian Inst Technol, Dept Drug Discovery & Dev, Genoa, Italy
关键词
Carbon monoxide-releasing molecules; UW solution; Liver function; Isolated perfused liver; ISCHEMIA/REPERFUSION INJURY; LIVER-TRANSPLANTATION; MITOCHONDRIAL; PERFUSION; ISCHEMIA; SURVIVAL; TARGETS; STORAGE; GRAFT; HEME;
D O I
10.1016/j.cryobiol.2009.01.002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is increasing evidence that carbon monoxide (CO), a signaling molecule generated during the degradation of heme by heme oxygenase-1 (HO-1) in biological systems, has a variety of cytoprotective actions, including anti-hypoxic effects at low temperatures. However, during liver cold preservation, a direct effect needs to be established. Here, we designed a study to analyze the role of CO, delivered via a carbon monoxide-releasing molecule (CO-RM) in the maintenance of liver function, and integrity in rats during cold ischemia/reperfusion (CI/R) injury. We used an isolated normothermic perfused liver system (INPL) following a clinically relevant model of ex vivo 48 h cold ischemia stored in a modified University of Wisconsin (UW) solution, to determine the specific effects of CO in a rat model. CO was generated from 50 mu M tricarbonylchloro ruthenium-glycinato (CORM-3), a water-soluble transition metal carbonyl that exerts pharmacological activities via the liberation of controlled amounts of CO in biological systems. The physiological effects of CORM-3 were confirmed by the parallel use of a specific inactive compound (iCORM-3), which does not liberate CO in the cellular environment. CORM-3 addition was found to prevent the injury caused by cold storage by improving significantly the perfusion flow during reperfusion (by almost 90%), and by decreasing the intrahepatic resistance (by 88%) when compared with livers cold preserved in UW alone. Also, CORM-3 supplementation preserved good metabolic capacity as indicated by hepatic oxygen consumption, glycogen content, and release of lactate dehydrogenase. Liver histology was also partially preserved by CORM-3 treatment. Conclusions: These findings suggest that CO-RM could be utilized as adjuvant therapeutics in UW solutions to limit the injury sustained by donor livers during cold storage prior to transplantation, as has been similarly proposed for the heart, and kidney. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:248 / 255
页数:8
相关论文
共 50 条
  • [21] Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3)
    Clara Di Filippo
    Mauro Perretti
    Francesco Rossi
    Franca Ferraraccio
    Roberto Motterlini
    Michele D’Amico
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 137 - 144
  • [22] Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3)
    Di Filippo, Clara
    Perretti, Mauro
    Rossi, Francesco
    Ferraraccio, Franca
    Motterlini, Roberto
    D'Amico, Michele
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (02) : 137 - 144
  • [23] Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3)
    Soni, Hitesh
    Jain, Mukul
    Mehta, Anita A.
    THROMBOSIS RESEARCH, 2011, 127 (06) : 551 - 559
  • [24] Carbon monoxide releasing molecule 3 (CORM-3) inhibits arterial thrombosis in rats
    Kramkowski, K.
    Mogielnicki, A.
    Motterlini, R.
    Chlopicki, S.
    Buczko, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1014 - 1014
  • [25] A carbon monoxide-releasing molecule (CORM-3) abrogates polymorphonuclear granulocyte-induced activation of endothelial cells and mast cells
    Masini, Emanuela
    Vannacci, Alfredo
    Failli, Paola
    Mastroianni, Rosanna
    Giannini, Lucia
    Vinci, Maria Cristina
    Uliva, Caterina
    Motterlini, Roberto
    Mannaioni, Pier Francesco
    FASEB JOURNAL, 2008, 22 (09): : 3380 - 3388
  • [26] CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke
    Yabluchanskiy, Andriy
    Sawle, Philip
    Homer-Vanniasinkam, Shervanthi
    Green, Colin J.
    Foresti, Roberta
    Motterlini, Roberto
    CRITICAL CARE MEDICINE, 2012, 40 (02) : 544 - 552
  • [27] Carbon monoxide-releasing molecule, CORM-3, modulates alveolar macrophage M1/M2 phenotype in vitro
    Yamamoto-Oka, Hiroko
    Mizuguchi, Shinjiro
    Toda, Michihito
    Minamiyama, Yukiko
    Takemura, Shigekazu
    Shibata, Toshihiko
    Cepinskas, Gediminas
    Nishiyama, Noritoshi
    INFLAMMOPHARMACOLOGY, 2018, 26 (02) : 435 - 445
  • [28] Carbon monoxide-releasing molecule, CORM-3, modulates alveolar macrophage M1/M2 phenotype in vitro
    Hiroko Yamamoto-Oka
    Shinjiro Mizuguchi
    Michihito Toda
    Yukiko Minamiyama
    Shigekazu Takemura
    Toshihiko Shibata
    Gediminas Cepinskas
    Noritoshi Nishiyama
    Inflammopharmacology, 2018, 26 : 435 - 445
  • [29] A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia
    Desmard, Mathieu
    Davidge, Kelly S.
    Bouvet, Odile
    Morin, Didier
    Roux, Damien
    Foresti, Roberta
    Ricard, Jean D.
    Denamur, Erick
    Poole, Robert K.
    Montravers, Philippe
    Motterlini, Roberto
    Boczkowski, Jorge
    FASEB JOURNAL, 2009, 23 (04): : 1023 - 1031
  • [30] Metabolomics of Escherichia coli Treated with the Antimicrobial Carbon Monoxide-Releasing Molecule CORM-3 Reveals Tricarboxylic Acid Cycle as Major Target
    Carvalho, Sandra M.
    Marques, Joana
    Romao, Carlos C.
    Saraiva, Ligia M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (10)